{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:56:06Z","timestamp":1768208166492,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1038\/s41575-023-00773-4","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T10:02:57Z","timestamp":1681207377000},"page":"342-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Screening for Barrett oesophagus \u2014 a call for collaboration between gastroenterology and primary care"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4132-0014","authenticated-orcid":false,"given":"Arvind J.","family":"Trindade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"773_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.14309\/ajg.0000000000001680","volume":"117","author":"NJ Shaheen","year":"2022","unstructured":"Shaheen, N. J. et al. Diagnosis and management of Barrett\u2019s esophagus: an updated ACG guideline. Am. J. Gastroenterol. 117, 559\u2013587 (2022).","journal-title":"Am. J. Gastroenterol."},{"key":"773_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15760","author":"MC Tan","year":"2020","unstructured":"Tan, M. C. et al. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett\u2019s oesophagus in oesophageal adenocarcinoma patients. Aliment. Pharmacol. Ther. https:\/\/doi.org\/10.1111\/apt.15760 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"773_CR3","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1053\/j.gastro.2018.02.022","volume":"154","author":"DC Codipilly","year":"2018","unstructured":"Codipilly, D. C. et al. The effect of endoscopic surveillance in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis. Gastroenterology 154, 2068\u20132086.e5 (2018).","journal-title":"Gastroenterology"},{"key":"773_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","volume":"63","author":"RC Fitzgerald","year":"2014","unstructured":"Fitzgerald, R. C. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus. Gut 63, 7\u201342 (2014).","journal-title":"Gut"},{"key":"773_CR5","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.14309\/ajg.0000000000001935","volume":"117","author":"S Eluri","year":"2022","unstructured":"Eluri, S. et al. Low prevalence of endoscopic screening for Barrett\u2019s esophagus in a screening-eligible primary care population. Am. J. Gastroenterol. 117, 1764\u20131771 (2022).","journal-title":"Am. J. Gastroenterol."},{"key":"773_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2023.03.010","author":"M Stewart","year":"2023","unstructured":"Stewart, M. et al. Missed opportunities to screen for Barrett\u2019s esophagus in the primary care setting of a large health system. Gastrointest. Endosc. https:\/\/doi.org\/10.1016\/j.gie.2023.03.010 (2023).","journal-title":"Gastrointest. Endosc."},{"key":"773_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(20)31099-0","volume":"396","author":"RC Fitzgerald","year":"2020","unstructured":"Fitzgerald, R. C. et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett\u2019s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet 396, 333\u2013344 (2020).","journal-title":"Lancet"},{"key":"773_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001780","volume":"12","author":"CS Ross-Innes","year":"2015","unstructured":"Ross-Innes, C. S. et al. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett\u2019s esophagus: a multi-center case\u2013control study. PLoS Med. 12, e1001780 (2015).","journal-title":"PLoS Med."},{"key":"773_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao5848","author":"HR Moinova","year":"2018","unstructured":"Moinova, H. R. et al. Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett\u2019s esophagus. Sci. Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aao5848 (2018).","journal-title":"Sci. Transl Med."},{"key":"773_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.gie.2021.03.937","volume":"94","author":"PG Iyer","year":"2021","unstructured":"Iyer, P. G. et al. Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett\u2019s esophagus in a multisite case-control study. Gastrointest. Endosc. 94, 498\u2013505 (2021).","journal-title":"Gastrointest. Endosc."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-023-00773-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-023-00773-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-023-00773-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:02:38Z","timestamp":1685451758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-023-00773-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1038\/s41575-023-00773-4","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"11 April 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.J.T. receives research support from Lucid Diagnostics and is a consultant for Boston Scientific, Exact Science, Lucid Diagnostic and Pentax Medical. N.J.S. receives research funding from Interpace Diagnostics, Lucid Diagnostics, Medtronic, Pentax Medical and Steris, and is a consultant for Boston Scientific, Cernostics, CDx Diagnostics, Cook Medical, Exact Sciences and Phathom.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}